Leaflet GAVISCON FORTE MENTOL 500mg / 213mg / 325mg oral suspension


Indicated for: gastroesophageal reflux; acid dyspepsia

Route of administration: oral

Substance: sodium alginate + sodium bicarbonate (antacids)

ATC: A02BX13 (Alimentary tract and metabolism | Drugs for peptic ulcer and gastro-oesophageal reflux disease (gord) | Other drugs for peptic ulcer and gastro-oesophageal reflux disease (gord))

The combination of Natrii alginas + Natrii hydrogenocarbonas is used to treat gastroesophageal reflux and heartburn. It forms a protective barrier on the surface of the stomach contents, preventing acid reflux into the esophagus.

The medication is taken orally, usually in the form of chewable tablets or suspension. It is effective in providing rapid symptom relief and has a good safety profile.

Side effects are rare but may include bloating, nausea, or abdominal discomfort. It is important to follow the recommended dosage to avoid side effects.

Consult your doctor before use, especially if symptoms persist or if you have other gastrointestinal conditions. This medication is suitable for short-term use.

General data about GAVISCON FORTE MENTOL 500mg / 213mg / 325mg

  • Substance: sodium alginate + sodium bicarbonate
  • Date of last drug list: 01-05-2025
  • Commercial code: W71028001
  • Concentration: 500mg / 213mg / 325mg
  • Pharmaceutical form: oral suspension
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: OTC - Over the Counter = medicines that do not require a prescription.

Marketing authorisation

  • Manufacturer: RB NL BRANDS B.V. - TARILE DE JOS
  • Holder: RECKITT BENCKISER (ROMANIA) S.R.L. - ROMANIA
  • Number: 15574/2024/01
  • Shelf life: 2 years-after packing for marketing;after the first opening of the bottle-6 months

Pharmaceutical forms available for sodium alginate + sodium bicarbonate